A simple method for detecting complement-fixation by autologous platelets in autoimmune thrombocytopenic purpura.
A new modification of the microtitre complement fixation test, (CFT), is described for the detection of platelet-bound antibodies (PBA). The test was positive in 12 out of 16 patients, (75%), with active autoimmune thrombocytopenic purpura (AITP). It was negative in four patients who were in remission of AITP when tested, in 10 patients with non-immune thrombocytopenia and in 51 normal blood donors. This is a semi-quantitative method in which suspensions of the patients' own platelets consume complement and therefore prevent the lysis of sensitised sheep red cells (SRBC). Sera from some of these cases were also tested for serum anti-platelet antibody (SPA) and immune complexes. The possible mechanisms and the relevance of positive results are discussed.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001327:Autoimmune Diseases / Q000503:physiopathology*; D001792:Blood Platelets / Q000503:physiopathology*; D003168:Complement Fixation Tests / Q000379:methods*; D006801:Humans; D011696:Purpura, Thrombocytopenic / Q000503:physiopathology*
D000244:Adenosine Diphosphate